RICCARDI, ALBERTO
 Distribuzione geografica
Continente #
NA - Nord America 6.377
AS - Asia 4.763
EU - Europa 4.027
SA - Sud America 480
AF - Africa 113
Continente sconosciuto - Info sul continente non disponibili 65
OC - Oceania 32
Totale 15.857
Nazione #
US - Stati Uniti d'America 6.252
CN - Cina 2.575
SG - Singapore 1.096
UA - Ucraina 806
IE - Irlanda 753
FI - Finlandia 483
DE - Germania 470
HK - Hong Kong 438
SE - Svezia 363
BR - Brasile 359
RU - Federazione Russa 294
VN - Vietnam 259
IT - Italia 254
FR - Francia 244
GB - Regno Unito 221
IN - India 89
CA - Canada 75
AR - Argentina 48
ZA - Sudafrica 45
BD - Bangladesh 42
IQ - Iraq 30
TR - Turchia 28
JP - Giappone 27
MX - Messico 25
AU - Australia 24
BE - Belgio 21
PL - Polonia 21
MY - Malesia 20
ID - Indonesia 19
VE - Venezuela 18
CZ - Repubblica Ceca 17
PK - Pakistan 17
KR - Corea 16
CO - Colombia 13
NL - Olanda 13
CL - Cile 12
EC - Ecuador 12
EG - Egitto 12
UZ - Uzbekistan 12
JO - Giordania 11
MA - Marocco 11
ES - Italia 10
PH - Filippine 10
SA - Arabia Saudita 10
DZ - Algeria 8
GR - Grecia 8
IR - Iran 8
NZ - Nuova Zelanda 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
KE - Kenya 7
TH - Thailandia 7
CR - Costa Rica 6
ET - Etiopia 6
PE - Perù 6
AL - Albania 5
DO - Repubblica Dominicana 5
IL - Israele 5
PT - Portogallo 5
TW - Taiwan 5
BO - Bolivia 4
CH - Svizzera 4
DK - Danimarca 4
NP - Nepal 4
PY - Paraguay 4
RS - Serbia 4
AT - Austria 3
AZ - Azerbaigian 3
BY - Bielorussia 3
HU - Ungheria 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LT - Lituania 3
OM - Oman 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
AM - Armenia 2
BB - Barbados 2
BG - Bulgaria 2
BH - Bahrain 2
HN - Honduras 2
JM - Giamaica 2
LB - Libano 2
LK - Sri Lanka 2
MD - Moldavia 2
ML - Mali 2
MU - Mauritius 2
NG - Nigeria 2
PA - Panama 2
RO - Romania 2
TG - Togo 2
TT - Trinidad e Tobago 2
AI - Anguilla 1
AO - Angola 1
BF - Burkina Faso 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BW - Botswana 1
CI - Costa d'Avorio 1
CM - Camerun 1
Totale 15.775
Città #
Chandler 889
Jacksonville 861
Dublin 752
San Jose 729
Nanjing 615
Singapore 591
Ashburn 470
Hong Kong 422
Beijing 328
Boardman 286
Dallas 265
Nanchang 246
Council Bluffs 197
Princeton 197
Lawrence 174
Changsha 173
Shenyang 171
Hebei 158
Lauterbourg 155
Wilmington 136
Helsinki 135
Los Angeles 133
Medford 127
Jiaxing 111
Tianjin 110
Ho Chi Minh City 100
Hangzhou 96
Milan 86
Ann Arbor 74
Buffalo 69
Redondo Beach 62
Hanoi 57
New York 53
Munich 47
Houston 44
Verona 44
Moscow 41
Shanghai 41
Santa Clara 37
Woodbridge 37
Johannesburg 32
Toronto 31
Norwalk 30
Orem 29
Kunming 28
São Paulo 28
Chicago 25
San Francisco 24
Seattle 23
Guangzhou 22
Brooklyn 20
Brussels 20
Tokyo 20
Jinan 19
Atlanta 18
Warsaw 18
Frankfurt am Main 17
Chennai 16
Montreal 15
Zhengzhou 15
Boston 14
Falkenstein 14
Rio de Janeiro 14
Da Nang 13
Des Moines 13
Pavia 13
Baghdad 12
Mexico City 12
Turku 12
Auburn Hills 11
Belo Horizonte 11
Fairfield 11
Mumbai 11
San Genesio Ed Uniti 11
Stockholm 11
Melbourne 10
Dhaka 9
Manchester 9
Tashkent 9
Amman 8
Brno 8
Campinas 8
Denver 8
Falls Church 8
George Town 8
Haiphong 8
New Delhi 8
Ningbo 8
Nuremberg 8
Prague 8
Athens 7
Brasília 7
Can Tho 7
Haikou 7
Lanzhou 7
London 7
Secaucus 7
Sydney 7
Addis Ababa 6
Barquisimeto 6
Totale 10.145
Nome #
Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. 269
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 154
27P * Common gene signature expressed by breast and kidney cancers-derived endothelial colony forming cells 135
OEM-TACE: a new therapeutic approach in unresectable intrahepatic cholangiocarcinoma. 131
Use of bisphosphonates in oncology: physiopathologic bases and clinical activity. 129
Flow cytometric analysis of circulating dendritic cell subsets and intracellular cytokine production in advanced breast cancer patients 129
Response to first-line chemotherapy and long-term survival in patients with multiple myeloma: results of the MM87 prospective randomised protocol 128
Adding gemcitabine to paclitaxel/carboplatin combination increases survival in advanced non-small-cell lung cancer: results of a phase II-III study 128
A phase II study of sequential 5-fluorouracil, epirubicin and cyclophosphamide (FEC) and paclitaxel in advanced breast cancer (Protocol PV BC 97/01). 127
Cytokinetic changes in the peripheral blood of leukemic patients during cytostatic therapy. VI. Effect of arabinosylcytosine. 125
Cell kinetic characterization of human brain tumors 125
A study of biological behaviour of human brain tumors. Part I. Arachidonic acid metabolism and DNA content. 121
A plea to overcome th concept of "staging" and related inadequacy in multiple myeloma. 118
- Hematological values from quantitative buffy coat analysis (QBC II) system: evaluation in an hematological/oncological outpatient section 118
A prospective comparison of a-IFN and conventional chemotherapy in Ph+ chronic myeloid leukemia. Clinical and cytogenetic results at 2 years in 322 patients 118
Advanced breast cancer: a randomized study of different doses of epirubicin associated with fixed doses of cyclophosphamide and 5-fluorouracil. 117
Anemie in oncologia. 117
- GM-CSF increases dose intensity of chemotherapy in small cell lung cancer. Relationship between clinical results, peripheral blood cell modifications and bone marrow kinetics. 116
Complications of image-guided transcatheter hepatic chemoembolization of primary and secondary tumours of the liver. 116
In vitro killing of colorectal carcinoma cells by autologous activated NK cells is boosted by anti-epidermal growth factor receptor-induced ADCC regardless of RAS mutation status 115
AIDS-associated non-Hodgkin's lymphomas in Italy: intravenous drug abusers versus homosexual men 114
A prospective comparison of alpha-IFN and conventional chemotherapy in Ph+ chronic myeloid leukemia. Clinical and cytogenetic results at 2 years in 322 patients. The Italian Cooperative Study Group on Chronic Myeloid Leukemia. 114
G2 synchronization in human acute leukemia after VP 16 213 therapy. 111
A prospective comparison between treatment with phlebotomy alone and with interferon-alpha in patients with polycythemia vera. 111
Dendritic cells and vascular endothelial growth factor in colorectal cancer: correlations with clinicobiological findings. 111
Strategies of medical treatment for metastatic breast cancer 110
- Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: results from a multinational controlled trial. 110
Biological effects of pegfilgrastim on circulating neutrophils in breast cancer patients undergoing dose-dense chemotherapy. 110
VEGF-induced intracellular Ca2+oscillations are down-regulated and do not stimulate angiogenesis in breast cancer-derived endothelial colony forming cells 109
Long-term effects of parenteral dichloromethylene bisphosphonate (CL2MBP) on bone disease of myeloma patients treated with chemotherapy. 108
Anemie megaloblastiche. 108
Linee guida per la diagnosi, il trattamento e la riabilitazione del carcinoma polmonare 107
Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer: results and open issues. 106
Anemie megaloblastiche. 106
A prospective, controlled, nonrandomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple-myeloma. 106
Breast and renal cancer—Derived endothelial colony forming cells share a common gene signature 106
A rapid cytofluorometric method for quantitative DNA determination on fixed smears. 105
The PAS reactivity of lymph-node blast cells in non-Hodgkin's malignant lymphomas. 104
Effect of recombinant gamma interferon on the proliferative activity of cultured leukemic cells. 104
Cytokinetic changes in the peripheral blood of leukemic patients during cytostatic therapy. V. Effect of VP 16 213 studied with flow cytofluorometry and cytoautoradiography. 102
Presentation features of monoclonal gammopathies: analysis of 684 newly diagnosed cases. 101
P-glycoprotein expression in multiple myeloma. 101
New agents in medical oncology and the risk of venous thromboembolism. 101
Intravenous or oral vinorelbine plus capecitabine as first - line treatment in HER2- metastatic breast cancer: Joint Analysis of 2 Consecutive Prospective Phase II Trials. 100
Changing clinical presentation of multiple myeloma. 100
Adjuvant chemotherapy in gastric cancer: 5-year results of a randomized study by the Italian Trials in Medical Oncology (ITMO) Group. 100
Double heterozygosity for haemoglobin Malmø [ß97 (FG4) His-Glu] and ß-thalassemia traits, with unusually high haematocrit values, in a Sicilian man. 99
Unusual manifestations of disseminated neoplasia at presentation: right-sided heart failure due to a massive cardiac metastasis and autoimmune thrombocytopenia in pleomorphic rhabdomyosarcoma of the adult. 99
Microwave ablation of hepatocellular carcinoma using a new percutaneous device: preliminary results. 99
Intrathecal methotrexate neurotoxicity. 98
Cytokinetic studies in two cases of plasma cell leukemia. 98
Sequential intrahepatic and systemic fluoropyrimidines-based chemotherapy for metastatic colorectal cancer confined to the liver. A phase II study. 97
Left ventricular function in colon cancer patients receiving adjuvant fluoro-folate chemotherapy. An echocardiographic study. 97
Relevance of age on survival of 341 patients with multiple myeloma treated with conventional chemotherapy: updated results of the MM87 prospective randomised protocol. 97
Ploidy and proliferative activity in uterine tumors: an in vivo study using bromodeoxyuridine and flow cytometry. 96
Sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following intensified, accelerated CEE (cyclophosphamide, epirubicin, etoposide) chemotherapy: cytokinetic effects on bone marrow hematopoietic progenitors. 96
Biologia e clinica del mieloma multiplo. 96
Pro-neoangiogenic cytokines (VEGF and bFGF) and anemia in solid tumor patients 96
Sequential docetaxel and vinorelbine for patients with advanced breast cancer previously treated with anthracyclines: a phase II study. 95
Effects of desferrrioxamine on normal and leukemic human hematopoietic cell growth: in vitro and in vivo studies 95
Serum thymidine kinase in monoclonal gammopathies. A prospective study. The Cooperative Group for Study and Treatment of Multiple Myeloma. 95
Cell kinetics of CD34-positive hematopoietic cells following chemotherapy plus colony-stimulating factors in advanced breast cancer. 95
Gemcitabine and oxaliplatin to treat immunotherapy-resistant advanced renal cell carcinoma patients: final results of a single institution phase II study 95
Sequential vincristine, arabinosylcytosine and daunomycin in acute leukemia: a preliminary report. 95
DNA content analysis of peripheral blood B-lymphocytes in plasma cell malignancies 94
Central indwelling catheter to prevent phlebosclerosis by Peptichemio in patients with multiple myeloma 94
Preoperative Carbon Ion Radiotherapy (CIRT) with Chemotherapy in Resectable and Borderline Resectable Pancreatic Adenocarcinoma (PCa): A Multicenter Prospective Phase II Clinical Study (Pioppo Study NCT 03822936) 93
Weekly taxanes in metastatic breast cancer. 93
Doubling the epirubicin dosage in the 5-fluorouracil, epirubicin and cyclophosphamide (FEC) regimen for advanced breast cancer: a prospective, randomized, multicentric study on antitumor effect and life quality 93
I linfomi non Hodgkin (linfosarcomi, reticolosarcomi). 93
Fisiopatologia dell'eritrocito. 93
Cancer chemotherapy-related thrombotic thrombocytopeic purpura: biological evidence of increased nitric oxide production. 93
Studio morfologico e citochimico dei megacariociti in 25 casi di displasie emopoietiche. 92
Myelodysplastic syndromes: biologic and clinical aspects. 92
Il trattamento medico del carcinoma mammario. 92
Expression of p53 protein during the cell cycle mesaured by flow cytometry in human leukemia. 91
Cell kinetic studies of human intracranial tumors. 91
Recombinant human interleukin-11 (Neumega, rhIL-11) reduces thrombocytopenia in breast cancer patients receiving tandem autologous circulating progenitor cell transportation. 90
Intravenous or oral vinorelbine plus capecitabine as first-line treatment in HER2- metastatic breast cancer: joint analysis of 2 consecutive prospective phase II trials. 90
Acute rhabdomyolysis after high dose chemotherapy and circulating progenitor cell autografting for breast cancer. 90
The use of peripheral blood haemopoietic progenitors mobilized with standard dose chemotherapy plus G-CSF to support multicyclic dose-intensive chemotherapy for advanced breast cancer. 89
Interferon alpha-2b in the long-term treatment of essential thrombocythemia. 89
High-dose chemotherapy (HDT) with tandem autologous peripheral blood cells (PBPC) transplantation for patients with metastatic breast cancer (MBC) 89
La citofluorimetria a flusso nella diagnostica ematologica ed oncologica. 89
Deoxyribonucleic acid content of cleaved and non-cleaved cells in follicular center cell lymphomas. 89
Angiogenesi: esperienze cliniche 88
Myeloprotective effect of early primary granulocyte-colony stimulating factor during intensified 5-fluorouracil, epirubicin and cyclophosphamide (120FEC) chemotherapy for advanced breast cancer. 88
Prerequisites for in vivo cell kinetic studies in patients. 88
Interim analysis of the Grocta 8 adjuvant trial in breast cancer patients with ten or more involved nodes 88
Cell cycle status and apoptosis of hematopoietic progenitor cells released into the peripheral blood after taxanes anf granulocyte colony-stimulating factor in breast cancer patients 87
Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry 87
Fisiopatologia dell'eritrocito. 87
Applicazioni cliniche dei fattori di crescita emopoietici. 87
Effect of Vincristine on the bone marrow cells of patients with multiple myeloma: a cytomorphologic study. 86
Sustained complete hematological remission in essential thrombocythemia after discontinuation of long-term a-IFN treatment. 86
Cell kinetics with in vivo bromodeoxyuridine and flow cytometry: clinical significance in acute non lymphoblastic leukemia. 86
Transhepatic arterial chemoembolization with oxaliplatin-eluting microspheres (OEM-TACE) for Unresectable Hepatic Tumors. 86
Nuove strategie di impiego dei fattori di crescita mielopoietici. 85
Flow cytometric DNA index in the prognosis of colorectal cancer. 85
Simultaneous detection of cellular p21 ras oncogene product and DNA content by two parameter flow cytometry 85
Totale 10.357
Categoria #
all - tutte 64.022
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.022


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022805 0 2 21 11 20 32 19 31 41 16 127 485
2022/20232.425 301 127 25 238 317 257 0 134 914 14 53 45
2023/2024718 130 146 25 62 68 167 11 28 8 29 27 17
2024/20251.921 42 208 54 73 41 53 66 181 434 42 192 535
2025/20264.556 351 367 438 434 444 280 1.003 175 397 368 199 100
2026/2027321 103 218 0 0 0 0 0 0 0 0 0 0
Totale 15.857